Wednesday, November 29, 2017 11:01:01 AM
I've been in and out of CYTR since 2010 and have lost plenty of time and money in the process. While I'm down "big time" at the moment, I honestly feel that CYTR is onto something with LADR in general, and Aldox in particular. I've "learned" not to trust the CEO, and think his current change of character is more a result of SH's extreme dissatisfaction via lawsuits, etc..., rather than a genuine concern for them all of a sudden. Time will tell for sure.
I hope "we" are correct in the positive assessment of Aldox and CYTR's prospects for future clinical trial development and results. Everything seems to be in the CEO's hands at this point and we might be waiting a while before we see any monetary benefit from what Aldox or LADR have to offer. BUT, SOONer or LADR it will come.
Thanks again for your fact based response, and GLTY and CYTR!
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM